Cyclic diarylheptanoids inhibit cell-mediated low-density lipoprotein oxidation. 2006

Hyun-Mi Kang, and Ju Ryong Kim, and Tae-Sook Jeong, and Sung-Gyu Choi, and Young-Han Ryu, and Goo Taeg Oh, and Nam-In Baek, and Byoung-Mog Kwon
Korea Research Institute of Bioscience and Biotechnology, 52 Uendong, Yusung, Taejon 305-600, Republic of Korea.

Two cyclic diarylheptanoids, garugamblin-3 (1) and acerogenin L (2), isolated from the MeOH extract of the fruits of Alnus japonica Steud., inhibited human low-density lipoprotein (LDL) oxidation in the thiobarbituric acid-reactive substance assay with IC50 values of 2.9 and 1.7 microM, respectively, and they also inhibited cell-mediated LDL oxidation more than five times more strongly than that of a well-known antioxidant, probucol, at a concentration of 10 microM. 1 had no effect on the anti-atherogenesis in low-density lipoprotein receptor- deficient mice.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D005260 Female Females
D005638 Fruit The fleshy or dry ripened ovary of a plant, enclosing the seed or seeds. Berries,Legume Pod,Plant Aril,Plant Capsule,Aril, Plant,Arils, Plant,Berry,Capsule, Plant,Capsules, Plant,Fruits,Legume Pods,Plant Arils,Plant Capsules,Pod, Legume,Pods, Legume
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D001011 Aorta The main trunk of the systemic arteries. Aortas
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017392 Thiobarbituric Acid Reactive Substances Low-molecular-weight end products, probably malondialdehyde, that are formed during the decomposition of lipid peroxidation products. These compounds react with thiobarbituric acid to form a fluorescent red adduct. TBARs

Related Publications

Hyun-Mi Kang, and Ju Ryong Kim, and Tae-Sook Jeong, and Sung-Gyu Choi, and Young-Han Ryu, and Goo Taeg Oh, and Nam-In Baek, and Byoung-Mog Kwon
June 1997, Indian journal of biochemistry & biophysics,
Hyun-Mi Kang, and Ju Ryong Kim, and Tae-Sook Jeong, and Sung-Gyu Choi, and Young-Han Ryu, and Goo Taeg Oh, and Nam-In Baek, and Byoung-Mog Kwon
May 2008, Journal of agricultural and food chemistry,
Hyun-Mi Kang, and Ju Ryong Kim, and Tae-Sook Jeong, and Sung-Gyu Choi, and Young-Han Ryu, and Goo Taeg Oh, and Nam-In Baek, and Byoung-Mog Kwon
October 1995, The Journal of laboratory and clinical medicine,
Hyun-Mi Kang, and Ju Ryong Kim, and Tae-Sook Jeong, and Sung-Gyu Choi, and Young-Han Ryu, and Goo Taeg Oh, and Nam-In Baek, and Byoung-Mog Kwon
January 2007, Fitoterapia,
Hyun-Mi Kang, and Ju Ryong Kim, and Tae-Sook Jeong, and Sung-Gyu Choi, and Young-Han Ryu, and Goo Taeg Oh, and Nam-In Baek, and Byoung-Mog Kwon
August 1991, Atherosclerosis,
Hyun-Mi Kang, and Ju Ryong Kim, and Tae-Sook Jeong, and Sung-Gyu Choi, and Young-Han Ryu, and Goo Taeg Oh, and Nam-In Baek, and Byoung-Mog Kwon
April 1996, Redox report : communications in free radical research,
Hyun-Mi Kang, and Ju Ryong Kim, and Tae-Sook Jeong, and Sung-Gyu Choi, and Young-Han Ryu, and Goo Taeg Oh, and Nam-In Baek, and Byoung-Mog Kwon
January 1990, The International journal of biochemistry,
Hyun-Mi Kang, and Ju Ryong Kim, and Tae-Sook Jeong, and Sung-Gyu Choi, and Young-Han Ryu, and Goo Taeg Oh, and Nam-In Baek, and Byoung-Mog Kwon
February 2001, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP,
Hyun-Mi Kang, and Ju Ryong Kim, and Tae-Sook Jeong, and Sung-Gyu Choi, and Young-Han Ryu, and Goo Taeg Oh, and Nam-In Baek, and Byoung-Mog Kwon
June 2001, Cardiovascular research,
Hyun-Mi Kang, and Ju Ryong Kim, and Tae-Sook Jeong, and Sung-Gyu Choi, and Young-Han Ryu, and Goo Taeg Oh, and Nam-In Baek, and Byoung-Mog Kwon
December 2001, Italian heart journal : official journal of the Italian Federation of Cardiology,
Copied contents to your clipboard!